Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.0055.88%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.91M | 3.37M | 3.39M | 2.38M | 2.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.07M | 3.55M | 3.58M | 2.58M | 2.61M |
| Operating Income | -3.07M | -3.55M | -3.58M | -2.58M | -2.61M |
| Income Before Tax | -3.40M | -3.87M | -3.99M | -2.97M | -3.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.40 | -3.87 | -3.99 | -2.97 | -3.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.40M | -3.87M | -3.99M | -2.97M | -3.03M |
| EBIT | -3.07M | -3.55M | -3.58M | -2.58M | -2.61M |
| EBITDA | -3.05M | -3.52M | -3.55M | -2.55M | -2.59M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.15B | 4.15B | 4.14B | 4.14B | 4.13B |
| Average Diluted Shares Outstanding | 4.15B | 4.15B | 4.14B | 4.14B | 4.13B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |